Cargando…
Treatment of progressive multiple sclerosis with high-dose all-trans retinoic acid – no clear evidence of positive disease modifying effects
BACKGROUND: All-trans retinoic acid (ATRA) is an acid derivative of vitamin A which is discussed as a promising candidate to ameliorate the disease course of multiple sclerosis (MS) by immunomodulation or even by promoting regeneration in progressive MS. Here we report a patient who significantly im...
Autores principales: | Ruschil, Christoph, Dubois, Evelyn, Stefanou, Maria-Ioanna, Kowarik, Markus Christian, Ziemann, Ulf, Schittenhelm, Marcus, Krumbholz, Markus, Bischof, Felix |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108354/ https://www.ncbi.nlm.nih.gov/pubmed/33966627 http://dx.doi.org/10.1186/s42466-021-00121-4 |
Ejemplares similares
-
Human immunodeficiency virus and multiple sclerosis: a review of the literature
por: Stefanou, Maria-Ioanna, et al.
Publicado: (2019) -
No evidence of oligoclonal bands, intrathecal immunoglobulin synthesis and B cell recruitment in acute ischemic stroke
por: Laichinger, Kornelia, et al.
Publicado: (2023) -
Clinical-Radiological Mismatch in Multiple Sclerosis Patients during Acute Relapse: Discrepancy between Clinical Symptoms and Active, Topographically Fitting MRI Lesions
por: Dünschede, Jutta, et al.
Publicado: (2023) -
Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab
por: Kemmerer, C. L., et al.
Publicado: (2020) -
Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers in Primary Progressive Multiple Sclerosis and Hereditary Spastic Paraplegia Type 4
por: Kessler, Christoph, et al.
Publicado: (2022)